Share
Journal Information
Original
Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome
Reducción del inhibidor de la fibrinólisis activado por trombina y aumento de las citocinas proinflamatorias en pacientes son síndrome coronario agudo
a Department of Biomedical Engineering, Dalian University of Technology, No. 2 Ling Gong Road, Ganjingzi District, Dalian city 116024, China
b Vasculocardiology Department of the First Affiliated Hospital, Jinzhou Medical University, No. 2 of Street 5, Guta District, Jinzhou city 121000, China
c Technology Center of Liaoning MEDI Biological Company, No. 166 of Xianghuai Road, Economic and Technological Development Zone, Benxi city 117004, China
Article
This article is available in English
Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome
H. Pang, C. Zhang, F. Liu, X. Gong, X. Jin, C. Su
10.1016/j.medine.2016.10.012Med Intensiva. 2017;41:475-82
Publish in
Medicina Intensiva
Free access articles
Med Intensiva. 2023;47:563-4
Med Intensiva. 2023;47:491-2
